Sanofi to start human trials of its second coronavirus vaccine candidate | Inquirer News

Sanofi to start human trials of its second coronavirus vaccine candidate

/ 04:59 PM March 12, 2021

This picture taken on November 23, 2020 shows a bottle reading “Vaccine Covid-19” next to French biopharmaceutical company Sanofi logo on November 23, 2020. (Photo by JOEL SAGET / AFP)

PARIS — French pharmaceutical firm Sanofi on Friday announced the launch of human trials of its second COVID-19 vaccine, with its first still in the testing phase after having fallen behind in development.

Sanofi and US company Translate Bio are developing the vaccine based on messenger RNA technology.

Article continues after this advertisement

The phase 1 and 2 trials aim to verify that the vaccine is not dangerous and to provide initial information on its effectiveness.

FEATURED STORIES

Phase 3 would be carried out on many more patients to determine its effectiveness.

The first trials will include 415 people, with inital results expected in the third quarter.

Article continues after this advertisement

Messenger RNA technology is also used in the Pfizer/BioNTech and Moderna vaccines, already authorized in the European Union, the United States and elsewhere.

Article continues after this advertisement

It is the second vaccine developed by Sanofi against the coronavirus.

Article continues after this advertisement

An earlier candidate, developed with Britain’s GSK, is recombinant protein-based, but its development is several months behind schedule and testing is only in phase 2, with hopes to launch it in late 2021.

Sanofi has also agreed to help produce COVID vaccines developed by Pfizer and Johnson & Johnson.

Your subscription could not be saved. Please try again.
Your subscription has been successful.

Subscribe to our daily newsletter

By providing an email address. I agree to the Terms of Use and acknowledge that I have read the Privacy Policy.

For more news about the novel coronavirus click here.
What you need to know about Coronavirus.
For more information on COVID-19, call the DOH Hotline: (02) 86517800 local 1149/1150.

The Inquirer Foundation supports our healthcare frontliners and is still accepting cash donations to be deposited at Banco de Oro (BDO) current account #007960018860 or donate through PayMaya using this link.

TAGS: COVID-19, France, Sanofi

Your subscription could not be saved. Please try again.
Your subscription has been successful.

Subscribe to our newsletter!

By providing an email address. I agree to the Terms of Use and acknowledge that I have read the Privacy Policy.

© Copyright 1997-2024 INQUIRER.net | All Rights Reserved

This is an information message

We use cookies to enhance your experience. By continuing, you agree to our use of cookies. Learn more here.